Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2009 1
2010 4
2011 7
2012 14
2013 13
2014 4
2015 3
2016 2
2017 2
2018 2
2019 4
2020 4
2021 3
2022 8
2023 3
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Ukraine strong.
Yoshida EM, Chandok N. Yoshida EM, et al. Among authors: chandok n. Can Liver J. 2022 May 9;5(2):101-102. doi: 10.3138/canlivj-2022-0008. eCollection 2022 Spring. Can Liver J. 2022. PMID: 35991482 Free PMC article. No abstract available.
The untitled editorial.
Yoshida EM, Chandok N. Yoshida EM, et al. Among authors: chandok n. Can Liver J. 2023 Dec 20;6(4):373-374. doi: 10.3138/canlivj-2023-0029. eCollection 2023 Dec. Can Liver J. 2023. PMID: 38152321 Free PMC article. No abstract available.
Five years after….
Chandok N, Yoshida EM. Chandok N, et al. Can Liver J. 2023 Feb 28;6(1):1. doi: 10.3138/canlivj-2022-12-12. eCollection 2023 Feb. Can Liver J. 2023. PMID: 36908572 Free PMC article. No abstract available.
Hepatology and the humanities.
Yoshida EM, Chandok N. Yoshida EM, et al. Among authors: chandok n. Can Liver J. 2024 Feb 26;7(1):1-2. doi: 10.3138/canlivj-2024-0005. eCollection 2024 Feb. Can Liver J. 2024. PMID: 38505783 Free PMC article. No abstract available.
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, Kohli A, Sarin S, Caldwell SH, Alkhouri N, Shiffman ML, Camargo M, Li G, Kersey K, Jia C, Zhu Y, Djedjos CS, Subramanian GM, Myers RP, Gunn N, Sheikh A, Anstee QM, Romero-Gomez M, Trauner M, Goodman Z, Lawitz EJ, Younossi Z; STELLAR-3; STELLAR-4 Investigators. Harrison SA, et al. J Hepatol. 2020 Jul;73(1):26-39. doi: 10.1016/j.jhep.2020.02.027. Epub 2020 Mar 6. J Hepatol. 2020. PMID: 32147362 Clinical Trial.
Hepatology in the time of COVID-19: Part 2.
Yoshida EM, Chandok N. Yoshida EM, et al. Among authors: chandok n. Can Liver J. 2022 Nov 7;5(4):437-438. doi: 10.3138/canlivj-2022-09-04. eCollection 2022 Nov. Can Liver J. 2022. PMID: 38144410 Free PMC article. No abstract available.
The benefits of a team approach to cirrhosis care.
Chauhan P, Chandok N. Chauhan P, et al. Among authors: chandok n. Can Liver J. 2023 Oct 30;6(3):291-294. doi: 10.3138/canlivj-2023-0017. eCollection 2023 Oct. Can Liver J. 2023. PMID: 38020193 Free PMC article. No abstract available.
77 results